Pick Dr Reddy's Laboratories: Phani Sekhar

Phani Sekhar of Angel Broking told CNBC-TV18, "In Dr Reddy's Laboratories from here things might not be as bad as the stock price suggests today. I guess it is a good opportunity for longer term investors because even if you combine Russia, Venezuela and all the troubled economies it is not more than 18-20 percent and that is also primarily a currency risk which has more or less stabilised. So, it is a good opportunity for investors to get into this."

Dr Reddys Laboratories ended at Rs 3,129.85, down Rs 9.30, or 0.30 percent on the BSE.

The share touched its 52-week high Rs 3,662 and 52-week low Rs 2,250 on 01 December, 2014 and 19 May, 2014, respectively.